Surveillance RS were collected using
E-swab (Copan, Brescia, Italy), inoculated onto a chromogenic medium (Kima Meus, Arzegrande, Italy) containing a carbapenem antibiotic as selective agent and incubated at 35e37 C for 18e24 hours. Clinical isolates were processed following standard procedures. Species identification and routine antimicrobial susceptibility testing were performed using
Vitek-MS MALDI-TOF and
VITEK2 systems (bioM erieux, Marcy l'Etoile, France). Results for MIC were interpreted according to EUCAST breakpoints. For all Enterobacterales isolates with MIC values higher than the EUCAST cut-off for at least one of the tested carbapenems (ertapenem, imipenem, meropenem), carbapenemase production was evaluated. Different confirmation methods have been used from 2010 to 2017, including modified Hodg
E-test, disc diffusion synergy test with inhibitors (Rosco Diagnostika, Taastrup, Denmark), lateral flow immunoassays (Coris BioConcept, Gembloux, Belgium), the Neo-Rapid carb sCPEen test (Rosco Diagnostika) [12] and Xpert Carba-R molecular method (Cepheid, Sunnyvale, CA, USA) [13] . In addition, carbapenem MICs were confirmed by
E-test (Biom erieux).
Giannella M., Bartoletti M., Campoli C., Rinaldi M., Coladonato S., Pascale R., Tedeschi S., Ambretti S., Cristini F., Tumietto F., Siniscalchi A., Bertuzzo V., Morelli M.C., Cescon M., Pinna A.D., Lewis R, & Viale P. (2019). The impact of carbapenemase-producing Enterobacteriaceae colonization on infection risk after liver transplantation: a prospective observational cohort study. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 25(12).